Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Assembly Biosciences (ASMB) Accumulated Depreciation & Amortization (2016 - 2023)

Assembly Biosciences (ASMB) has 9 years of Accumulated Depreciation & Amortization data on record, last reported at $210000.0 in Q4 2023.

  • For Q4 2023, Accumulated Depreciation & Amortization fell 87.55% year-over-year to $210000.0; the TTM value through Dec 2023 reached $210000.0, down 87.55%, while the annual FY2023 figure was $210000.0, 87.55% down from the prior year.
  • Accumulated Depreciation & Amortization reached $210000.0 in Q4 2023 per ASMB's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.8 million in Q4 2020 and bottomed at $135000.0 in Q1 2019.
  • Average Accumulated Depreciation & Amortization over 5 years is $1.1 million, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 854.81% in 2020, then crashed 87.55% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.2 million in 2019, then surged by 53.0% to $1.8 million in 2020, then plummeted by 34.26% to $1.2 million in 2021, then soared by 39.77% to $1.7 million in 2022, then plummeted by 87.55% to $210000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $210000.0 in Q4 2023, $1.7 million in Q4 2022, and $1.2 million in Q4 2021.